Nairo Quintana’s Tour de France tramadol disqualification upheld

CAS uphold the UCI decision to disqualify the Colombian after painkiller detected in blood tests

Nairo Quintana
(Image credit: Getty)

The decision to disqualify Nairo Quintana from the 2022 Tour de France by the UCI has been upheld by the Court of Arbitration for Sport [CAS]. 

Quintana returned a positive test during the race for tramadol on two separate occasions.

Thank you for reading 20 articles this month* Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read 5 free articles per month without a subscription

Join now for unlimited access

Try first month for just £1 / $1 / €1

Tom Thewlis
News and Features Writer

After previously working in higher education, Tom joined Cycling Weekly in 2022 and hasn't looked back. He's been covering professional cycling ever since; reporting on the ground from some of the sport's biggest races and events, including the Tour de France, Paris-Roubaix and the World Championships. His earliest memory of a bike race is watching the Tour on holiday in the early 2000's in the south of France - he even made it on to the podium in Pau afterwards. His favourite place that cycling has taken him is Montréal in Canada.